|
ZNF585A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.423300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.978400E-01 |
| Normal-vs-Stage2 |
1.953780E-01 |
| Normal-vs-Stage3 |
1.09419999949623E-07 |
| Normal-vs-Stage4 |
2.17540000002625E-06 |
| Stage1-vs-Stage2 |
4.453600E-01 |
| Stage1-vs-Stage3 |
2.57240000001158E-06 |
| Stage1-vs-Stage4 |
5.92440000000138E-05 |
| Stage2-vs-Stage3 |
1.695520E-02 |
| Stage2-vs-Stage4 |
2.731600E-02 |
| Stage3-vs-Stage4 |
9.705000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.407700E-04 |
| Normal-vs-AfricanAmerican |
2.504200E-02 |
| Normal-vs-Asian |
6.344800E-01 |
| Caucasian-vs-AfricanAmerican |
5.538000E-01 |
| Caucasian-vs-Asian |
1.686560E-01 |
| AfricanAmerican-vs-Asian |
1.628650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.695680E-03 |
| Normal-vs-Female |
3.982600E-03 |
| Male-vs-Female |
9.980600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.386810E-01 |
| Normal-vs-Age(41-60Yrs) |
1.473360E-01 |
| Normal-vs-Age(61-80Yrs) |
2.09619999999022E-05 |
| Normal-vs-Age(81-100Yrs) |
3.542300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.589400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.480800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.352000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.356300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.501400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.897800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.696200E-02 |
| Normal-vs-Grade 2 |
4.278200E-01 |
| Normal-vs-Grade 3 |
3.50350000000166E-05 |
| Normal-vs-Grade 4 |
1.66320002215059E-09 |
| Grade 1-vs-Grade 2 |
2.126000E-02 |
| Grade 1-vs-Grade 3 |
2.160400E-04 |
| Grade 1-vs-Grade 4 |
8.54379999970512E-07 |
| Grade 2-vs-Grade 3 |
7.554700E-04 |
| Grade 2-vs-Grade 4 |
1.74169999977991E-07 |
| Grade 3-vs-Grade 4 |
3.384200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.817800E-01 |
| Normal-vs-ccB subtype |
5.57679999999561E-05 |
| ccA subtype-vs-ccB subtype |
3.72610000000106E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.159500E-03 |
| Normal-vs-N1 |
3.261700E-02 |
| N0-vs-N1 |
2.184600E-01 |
|
|
